» Articles » PMID: 39778978

Quantitative Assessment of Deep Gray Matter Susceptibility and Correlation With Cognition in Patients With Liver Cirrhosis

Overview
Journal Brain Behav
Date 2025 Jan 8
PMID 39778978
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Accumulation of metals quantified by quantitative susceptibility mapping (QSM) in deep gray matter (DGM) and their impact on cognition have not been studied in patients with liver cirrhosis. This study aims to use QSM to investigate the association between DGM susceptibility and cognition in cirrhotic patients.

Methods: Thirty cirrhotic patients and 30 age-, gender-, and education-matched controls were imaged using a multiecho gradient-echo sequence for QSM analysis in a 3T scanner. The susceptibility values were determined for the caudate nucleus (CN), putamen (PU), globus pallidus (GP), thalamus (TH), red nucleus (RN), substantia nigra (SN), and dentate nucleus (DN). All subjects underwent number connection test A (NCT-A), digit substitution test (DST), and Montreal Cognitive Assessment (MoCA). Comparisons between the two groups and the correlation between the susceptibility values and neuropsychological scores were analyzed.

Results: The susceptibility values of bilateral CN, TH, and RN were significantly lower in cirrhotic patients. Cirrhotic patients exhibited significantly prolonged NCT-A time and decreased DST and MoCA scores. The NCT-A, DST, MoCA, and sub-domain scores were correlated with susceptibility values of RN, DN, SN, and CN, respectively. The susceptibility value of the left RN was a predictor variable for the DST, MoCA, and visuospatial-executive scores; those of the right CN and left RN were predictor variables for the naming score, and that of the left SN was an independent predictor variable for the language score.

Conclusions: Altered susceptibility values of DGM measured by QSM are potential quantitative indicators of cognitive impairment in cirrhotic patients.

References
1.
Kim H, Lee H, Lee W, Kim Y, Jang H, Byun K . Pattern approach to MR imaging in patients with end-stage hepatic failure: a proposal for a new disease entity "hepatic encephalopathy continuum". Neuroradiology. 2008; 50(8):683-91. DOI: 10.1007/s00234-008-0395-5. View

2.
Basile G, Quartu M, Bertino S, Serra M, Boi M, Bramanti A . Red nucleus structure and function: from anatomy to clinical neurosciences. Brain Struct Funct. 2020; 226(1):69-91. PMC: 7817566. DOI: 10.1007/s00429-020-02171-x. View

3.
Montagnese S, Bajaj J . Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. Drugs. 2019; 79(Suppl 1):11-16. PMC: 6416233. DOI: 10.1007/s40265-018-1019-y. View

4.
Ye M, Guo Z, Li Z, Lin X, Li J, Jiang G . Aberrant inter-hemispheric coordination characterizes the progression of minimal hepatic encephalopathy in patients with HBV-related cirrhosis. Neuroimage Clin. 2020; 25:102175. PMC: 6965735. DOI: 10.1016/j.nicl.2020.102175. View

5.
Jiang H, Li Z, Yang W, Sun Y, Yan F, Sun Q . Region-specific disturbed iron redistribution in Cushing's disease measured by magnetic resonance imaging-based quantitative susceptibility mapping. Clin Endocrinol (Oxf). 2022; 97(1):81-90. DOI: 10.1111/cen.14692. View